Serum Institute starts Covovax production; govt expects 200 mn doses by Dec

Serum Institute of India (SII) said on Friday that production of the first batch of Covovax, the Covid-19 vaccine developed by US-based Novavax, has started in Pune.
 
The Centre expects 200 million doses of Covovax to be available between August and December. India will allow entry of this vaccine once the USFDA approves it.
 
In a tweet, on its official handle, the company said, “A new milestone has been reached; this week we began our first batch of Covovax at our facility, here in Pune.”
 
The company has been stockpiling Covovax doses for some time now. This